DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,109 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $405,284 | -28.9% | 1,634 | -26.1% | 0.08% | -25.0% |
Q2 2023 | $570,275 | -21.6% | 2,211 | -24.7% | 0.11% | -28.9% |
Q1 2023 | $727,377 | +1.4% | 2,937 | +8.7% | 0.15% | -7.9% |
Q4 2022 | $717,302 | -1.5% | 2,703 | -4.1% | 0.16% | -12.2% |
Q3 2022 | $728,000 | +1.8% | 2,819 | +0.0% | 0.19% | +4.4% |
Q2 2022 | $715,000 | -17.7% | 2,818 | -6.8% | 0.18% | -7.2% |
Q1 2022 | $869,000 | -22.7% | 3,022 | -11.6% | 0.19% | -24.5% |
Q4 2021 | $1,124,000 | -1.6% | 3,417 | -8.9% | 0.26% | -4.5% |
Q3 2021 | $1,142,000 | +13.5% | 3,752 | +0.1% | 0.27% | +6.7% |
Q2 2021 | $1,006,000 | -29.9% | 3,750 | -36.7% | 0.25% | -34.0% |
Q1 2021 | $1,436,000 | -7.2% | 5,921 | -6.9% | 0.38% | +7.3% |
Q4 2020 | $1,548,000 | +16.0% | 6,359 | +2.7% | 0.36% | -0.6% |
Q3 2020 | $1,334,000 | +19.3% | 6,193 | -2.1% | 0.36% | +7.5% |
Q2 2020 | $1,118,000 | +21.3% | 6,323 | -5.0% | 0.33% | -7.5% |
Q1 2020 | $922,000 | -9.8% | 6,658 | +0.0% | 0.36% | +2.3% |
Q4 2019 | $1,022,000 | +5.5% | 6,656 | -0.8% | 0.35% | -2.8% |
Q3 2019 | $969,000 | +1.5% | 6,711 | +0.5% | 0.36% | +4.0% |
Q2 2019 | $955,000 | -7.6% | 6,679 | -14.7% | 0.35% | -8.7% |
Q1 2019 | $1,034,000 | +37.7% | 7,833 | +7.6% | 0.38% | +26.6% |
Q4 2018 | $751,000 | -2.7% | 7,278 | +2.5% | 0.30% | +7.1% |
Q3 2018 | $772,000 | -2.3% | 7,100 | -11.3% | 0.28% | +1.1% |
Q2 2018 | $790,000 | -4.2% | 8,009 | -9.9% | 0.28% | -9.4% |
Q4 2017 | $825,000 | +6.7% | 8,885 | -1.4% | 0.31% | +5.9% |
Q3 2017 | $773,000 | -6.0% | 9,010 | -7.5% | 0.29% | -10.8% |
Q2 2017 | $822,000 | -2.5% | 9,741 | -1.1% | 0.32% | +2.2% |
Q1 2017 | $843,000 | +3.4% | 9,851 | -6.0% | 0.32% | -7.6% |
Q4 2016 | $815,000 | -7.6% | 10,479 | -7.0% | 0.34% | -5.5% |
Q3 2016 | $882,000 | -14.2% | 11,269 | +10.8% | 0.36% | -32.7% |
Q2 2016 | $1,028,000 | -99.9% | 10,173 | -7.6% | 0.54% | +19.7% |
Q1 2016 | $963,924,000 | +107963.2% | 11,014 | +14.8% | 0.45% | +11.3% |
Q4 2015 | $892,000 | +17.4% | 9,591 | +7.5% | 0.41% | -28.5% |
Q3 2015 | $760,000 | +1001.4% | 8,924 | +997.7% | 0.57% | +1059.2% |
Q2 2015 | $69,000 | -99.9% | 813 | -0.9% | 0.05% | +2.1% |
Q1 2015 | $69,618,000 | +99354.3% | 820 | 0.0% | 0.05% | -5.9% |
Q4 2014 | $70,000 | +11.1% | 820 | 0.0% | 0.05% | +2.0% |
Q3 2014 | $63,000 | -97.6% | 820 | +2384.8% | 0.05% | +2400.0% |
Q2 2014 | $2,598,000 | +5.0% | 33 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $2,475,000 | – | 33 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |